 |
|
|
| |
Diabetes, Weight Gain, & Integrase Inhibitor Use in North American HIV+ Persons
|
| |
| |
CROI 2020
Reported by Jules Levin
Peter F. Rebeiro1, Cathy A. Jenkins1, Aihua Bian1, Jordan E. Lake2, KassemBourgi3, Keri N. Althoff4, Michelle Floris-Moore5
Michael A. Horberg6, Janet Tate7, Amanda Willig8, Richard D. Moore4, Stephen J. Gange4, Timothy R. Sterling1, and John R. Koethe1 for the NA-ACCORD
1. Vanderbilt University School of Medicine, Nashville, TN; 2. University of Texas at Houston, Houston, TX; 3. Indiana University, Indianapolis, IN; 4. Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;
5. University of North Carolina at Chapel Hill, Chapel Hill, NC; 6. Kaiser Permanente Mid-Atlantic States, Rockville, MD; 7.VA Connecticut Healthcare System, West Haven, CT; 8. University of Alabama at Birmingham, Birmingham, AL
|
| |
|
|
|
|
|
